with a mean increase of 8 points) and tirzepatide (SUMMIT), appears to be greater than what has been reported for other HFpEF trials investigating the benefits of angiotensin receptorneprilysin inhibitor (Paragon-HF), sodiumglucose cotransporter 2 inhibitors (EMPEROR-Preserved, DELIVER) and spironolactone (TOPCAT).3841 Unresolved Role of GLP-1RAs in Heart Failure with Reduced Ejection Fraction Unlike the positive results reported for GLP-1RAs in HFpEF, findings from dedicated trials in heart failure with reduced ejection fraction (HFrEF) report neutral findings
For instance, studies suggest that out of its 191 amino acid structure the N-terminal region exhibits an insulin-potentiating action, while amino acids 108 - 129 of hGH were found to evoke high mitogenic responses
365,366 To further investigate the antihypertensive potential of SCFAs, a phase II randomized controlled trial was conducted to evaluate HAMSAB, a high-fiber supplement designed to produce high levels of acetate and butyrate
173 Smith, H
If plateau persists despite dose escalation and lifestyle optimization, compound switching offers a fresh mechanism of action
That's because the drug works by targeting three gut hormones, including one called glucagon, which increases energy expenditure
